At the ACBS World Conference 2025, PsyTech VR showcased its innovative VR exposure therapy platform, designed to transform the treatment of anxiety, phobias, OCD, PTSD, and other mental health conditions. Represented by advisory board members Dr. Gwilym Roddick and Dr. Melanie Smith, the company engaged with clinicians on the benefits of integrating VR into therapeutic practices.
The platform, developed with science-backed usage protocols, offers mental health professionals a tool to create immersive, personalized environments for exposure therapy. Attendees had the opportunity to experience the technology firsthand, learning about its clinical applications for a range of disorders, including phobias, stress disorders, and addictions.
The response from the conference was overwhelmingly positive, with many clinicians expressing enthusiasm for the potential of VR to enhance cognitive behavioral therapy (CBT) and expand access to evidence-based care. Dr. Roddick highlighted the technology's ability to take exposure therapy beyond traditional methods, offering structured and immersive experiences that could redefine mental health treatment.
PsyTech VR's presence at the conference underscored the growing interest in VR as a therapeutic tool, signaling a shift towards more innovative and accessible mental health care solutions.
